Holocene Advisors, LP Novo Cure LTD Transaction History
Holocene Advisors, LP
- $22.6 Billion
- Q2 2024
A detailed history of Holocene Advisors, LP transactions in Novo Cure LTD stock. As of the latest transaction made, Holocene Advisors, LP holds 51,972 shares of NVCR stock, worth $811,282. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,972
Previous 169,417
69.32%
Holding current value
$811,282
Previous $2.65 Million
66.38%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding NVCR
# of Institutions
272Shares Held
77.2MCall Options Held
751KPut Options Held
293K-
Black Rock Inc. New York, NY12.1MShares$189 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA11.7MShares$183 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$174 Million0.0% of portfolio
-
State Street Corp Boston, MA3.01MShares$46.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.38MShares$37.1 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.64B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...